Vaccination of Balb/c mice against experimental visceral leishmaniasis with the GP36 glycoprotein antigen of Leishmania donovani (Q60227754)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11312005 AND SRC:MED&resulttype=core&format=json

6 November 2019

title

Vaccination of Balb/c mice against experimental visceral leishmaniasis with the GP36 glycoprotein antigen of Leishmania donovani (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11312005 AND SRC:MED&resulttype=core&format=json

6 November 2019

main subject

visceral leishmaniasis

1 reference

Leishmania donovani

1 reference

Clarisa Beatriz Palatnik-de-Sousa

inferred from title

author

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11312005 AND SRC:MED&resulttype=core&format=json

6 November 2019

author name string

E Paraguai de Souza

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11312005 AND SRC:MED&resulttype=core&format=json

6 November 2019

R R Bernardo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11312005 AND SRC:MED&resulttype=core&format=json

6 November 2019

M Palatnik

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11312005 AND SRC:MED&resulttype=core&format=json

6 November 2019

language of work or name

English

0 references

publication date

1 April 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11312005 AND SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11312005 AND SRC:MED&resulttype=core&format=json

6 November 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11312005 AND SRC:MED&resulttype=core&format=json

6 November 2019

issue

23-24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11312005 AND SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

3104-3115

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11312005 AND SRC:MED&resulttype=core&format=json

Controlled field trials of a vaccine against New World cutaneous leishmaniasis

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)50031-7

7 January 2021

Immune response in healthy volunteers vaccinated with killed leishmanial promastigotes plus BCG. I: Skin-test reactivity, T-cell proliferation and interferon-gamma production

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)50031-7

7 January 2021

Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran.

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)50031-7

7 January 2021

Double targeted gene replacement for creating null mutants

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)50031-7

7 January 2021

Development of a safe live Leishmania vaccine line by gene replacement.

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)50031-7

7 January 2021

Null mutants for the lmcpa cysteine proteinase gene in Leishmania mexicana

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)50031-7

7 January 2021

Recombinant vaccinia viruses expressing GP46/M-2 protect against Leishmania infection

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)50031-7

7 January 2021

Subunit vaccination of mice against new world cutaneous leishmaniasis: comparison of three proteins expressed in amastigotes and six adjuvants

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)50031-7

7 January 2021

Long-term protection of mice against Leishmania major with a synthetic peptide vaccine

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)50031-7

7 January 2021

Antigens shared by Leishmania species and Trypanosoma cruzi: immunological comparison of the acidic ribosomal P0 proteins

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)50031-7

7 January 2021

Vaccination with DNA Encoding the Immunodominant LACK Parasite Antigen Confers Protective Immunity to Mice Infected with Leishmania major

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)50031-7

7 January 2021

Lipophosphoglycan of Leishmania major that vaccinates against cutaneous leishmaniasis contains an alkylglycerophosphoinositol lipid anchor

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)50031-7

7 January 2021

Genetic vaccination against leishmaniasis

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)50031-7

7 January 2021

Leishmania donovani surface glycoconjugate GP36 is the major immunogen component of the Fucose-Mannose Ligand (FML)

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)50031-7

7 January 2021

A new approach to the phylogeny of Leishmania: species specificity of glycoconjugate ligands for promastigote internalization into murine macrophages

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)50031-7

7 January 2021

Vaccination of Swiss Albino mice against experimental visceral leishmaniasis with the FML antigen of Leishmania donovani.

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)50031-7

7 January 2021

Leishmania donovani: titration of antibodies to the fucose-mannose ligand as an aid in diagnosis and prognosis of visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)50031-7

7 January 2021

The fucose-mannose ligand-ELISA in the diagnosis and prognosis of canine visceral leishmaniasis in Brazil

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)50031-7

7 January 2021

Formulation of an immunogenic human cytomegalovirus vaccine: responses in mice

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)50031-7

7 January 2021

Formulation of the purified fusion protein of respiratory syncytial virus with the saponin QS-21 induces protective immune responses in Balb/c mice that are similar to those generated by experimental infection

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)50031-7

7 January 2021

Adjuvanticity and ISCOM formation by structurally diverse saponins

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)50031-7

7 January 2021

The FML (Fucose Mannose Ligand) of Leishmania donovani. a new tool in diagnosis, prognosis, transfusional control and vaccination against human kala-azar

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)50031-7

7 January 2021

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)50031-7

7 January 2021

Detection of monoclonal antibodies specific for carbohydrate epitopes using periodate oxidation

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)50031-7

7 January 2021

Roles of CR3 and mannose receptors in the attachment and ingestion of Leishmania donovani by human mononuclear phagocytes

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)50031-7

7 January 2021

The control of the antibody isotype response to recombinant human immunodeficiency virus gp120 antigen by adjuvants

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)50031-7

7 January 2021

Impact of the saponin adjuvant QS-21 and aluminium hydroxide on the immunogenicity of recombinant OspA and OspB of Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)50031-7

7 January 2021

A comparison of saponin with other adjuvants for the potentiation of protective immunity by a killed Plasmodium yoelii vaccine in the mouse

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)50031-7

7 January 2021

Saponin adjuvant primes for a dominant interleukin-10 production to ovalbumin and to Trypanosoma cruzi antigen

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)50031-7

7 January 2021

Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)50031-7

7 January 2021

Effective immunization of mice against cutaneous leishmaniasis using an intrinsically adjuvanted synthetic lipopeptide vaccine

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)50031-7

7 January 2021

Fatal visceral leishmaniasis in a strain of Swiss mice.

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(01)50031-7

7 January 2021

10.1016/S0264-410X(01)00031-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11312005 AND SRC:MED&resulttype=core&format=json

6 November 2019

1 reference